I

ICSGlobal Ltd
ASX:ICS

Watchlist Manager
ICSGlobal Ltd
ASX:ICS
Watchlist
Price: 0.4 AUD -81.82% Market Closed
Market Cap: AU$4.2m

Multiples-Based Value

ICS doesn't have a meaningful market cap.

There is not enough data to reliably calculate the multiples-based value of ICS.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ICS Multiples-Based Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

ICS Competitors Multiples
ICSGlobal Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
ICSGlobal Ltd
ASX:ICS
4.2m AUD 328.8 -14.2 -3 -3
US
CVS Health Corp
NYSE:CVS
89.1B USD 0.2 50.4 13.3 13.3
US
Cigna Group
XMUN:CGN
68B EUR 0.3 13.4 7.8 9.9
US
Cigna Corp
NYSE:CI
69B USD 0.3 11.6 0 0
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.8B EUR 1.1 19.5 9.3 13.8
DE
Fresenius Medical Care AG
XMUN:FME
22.5B EUR 1.2 23.3 9 16.6
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 1.6 24.8 11.9 17.3
US
Quest Diagnostics Inc
NYSE:DGX
21.5B USD 1.9 21.8 11.8 15.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR 0.5 11 5.3 9.8
US
Guardant Health Inc
NASDAQ:GH
11.1B USD 11.3 -26.6 -29.1 -26.4
US
DaVita Inc
NYSE:DVA
10.6B USD 0.8 14.2 7.3 9.8
P/E Multiple
Earnings Growth PEG
AU
I
ICSGlobal Ltd
ASX:ICS
Average P/E: 21.1
Negative Multiple: -14.2
N/A N/A
US
CVS Health Corp
NYSE:CVS
50.4
90%
0.6
US
C
Cigna Group
XMUN:CGN
13.4
19%
0.7
US
Cigna Corp
NYSE:CI
11.6
19%
0.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
19.5
26%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
23.3
16%
1.5
US
Laboratory Corporation of America Holdings
NYSE:LH
24.8
27%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
21.8
12%
1.8
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11
16%
0.7
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -26.6 N/A N/A
US
DaVita Inc
NYSE:DVA
14.2
20%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
I
ICSGlobal Ltd
ASX:ICS
Average EV/EBITDA: 9.5
Negative Multiple: -3
N/A N/A
US
CVS Health Corp
NYSE:CVS
13.3
28%
0.5
US
C
Cigna Group
XMUN:CGN
7.8
4%
2
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius SE & Co KGaA
XETRA:FRE
9.3
10%
0.9
DE
Fresenius Medical Care AG
XMUN:FME
9
7%
1.3
US
Laboratory Corporation of America Holdings
NYSE:LH
11.9
10%
1.2
US
Quest Diagnostics Inc
NYSE:DGX
11.8
6%
2
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
5.3
7%
0.8
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -29.1 N/A N/A
US
DaVita Inc
NYSE:DVA
7.3
4%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
I
ICSGlobal Ltd
ASX:ICS
Average EV/EBIT: 13.3
Negative Multiple: -3
N/A N/A
US
CVS Health Corp
NYSE:CVS
13.3
22%
0.6
US
C
Cigna Group
XMUN:CGN
9.9
5%
2
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius SE & Co KGaA
XETRA:FRE
13.8
12%
1.2
DE
Fresenius Medical Care AG
XMUN:FME
16.6
11%
1.5
US
Laboratory Corporation of America Holdings
NYSE:LH
17.3
18%
1
US
Quest Diagnostics Inc
NYSE:DGX
15.9
9%
1.8
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
9.8
11%
0.9
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -26.4 N/A N/A
US
DaVita Inc
NYSE:DVA
9.8
5%
2
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett